Home > Event > On-Demand Webinars > Commercial determinants of health and health inequalities

Commercial determinants of health and health inequalities

Our health is influenced by the conditions we are born, grow, live, work and age in the wider determinants of health. These include commercial determinants of health and health inequalities. We held the third webinar in this series sharing emerging findings from UKPRP-funded projects and exploring their implications for policy.

Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Key Considerations For Medicare Advantage Success

Change Healthcare

As one of the fastest-growing lines of business in health insurance, the Medicare Advantage market offers great potential for success. Launching a Medicare Advantage product requires a skillful approach to handling complex government requirements. Join Shelley Stevenson from Change Healthcare Consulting for an informative webinar that will help you better understand market dynamics. We’ll show you best practices for achieving compliance, high quality ratings, and desired revenue.

Watch Now

Women in Health IT at the Forefront of Addressing the Opioid Crisis

HIMSS Media

The objective of this webinar is to tie the opioid crisis with the Women in Health IT community to bring awareness to women’s voices in addressing the crisis. A panel of leaders at the federal and state levels and the HIE space will share their stories on how they came into their current work roles and what they are doing in those roles that ties to addressing the opioid crisis through information and technology.

Watch Now

Improving Sponsor Oversight of the Trial Master File at Chiesi

Regulators have made it abundantly clear - through recent guidance and inspection findings - that demonstrating sponsor oversight of an outsourced study is a critical requirement for TMF health and inspection-readiness.

Watch Now

The Importance of Accurate Chemical Characterization of Medical Devices Extractables

Chemical characterization of medical devices, involving the identification, quantification, and subsequent toxicological risk assessment of E&L compounds, is becoming increasingly accepted by regulatory agencies as a means to assess the biocompatibility of medical devices.

Watch Now